Wize Pharma, Inc. is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including DES.
Wize has in-licensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of DES, and other ophthalmological illnesses, including CCh and Sjögren's syndrome (Sjögren's).
LO2A is currently registered and marketed by its inventor in Germany and Switzerland for the treatment of DES, in Hungary for the treatment of DES, CCH and Sjögren's and in the Netherlands for the treatment of DES and Sjögren's.
Wize's strategy involves engaging local or multinational distributors to handle the distribution of LO2A.
Wize has finished a Phase II trial of LO2A for patients with CCH and is currently conducting a Phase IV study for LO2A for DES in patients with Sjögren's.
Company Details
- Employees
- 1
- Address
- Hod Hasharon, Israel 4527713, Il
- Phone
- +972 72 2600536
- in****@****rma.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- wizepharma.com
- Keywords
- Barcelona.
- HQ
- Hod Hasharon, Israel
Wize Pharma Questions
Wize Pharma's helpline number is +972 72 2600536
Wize Pharma's website is wizepharma.com
Wize Pharma's LinkedIn profile is https://il.linkedin.com/company/wize-pharma
Wize Pharma has
1 employees.
View email and phone details for 1
employees at Wize Pharma.
Wize Pharma's industry is
Pharmaceutical Manufacturing
Wize Pharma's top competitors are
Rayvio,
Innocells,
Sensil®,
Nanospun Technologies,
Vayeca,
Rxe2,
Axiv Materials,
Grevis Pharmaceuticals Pvt Ltd,
Msd Animal Health Israel,
Neurosense Therapeutics.
Wize Pharma's support email address is info@wizepharma.com
Wize Pharma's categories are Pharmaceutical Manufacturing
